Cardiac transplantation after the Fontan or Glenn procedure

K. Anitha Jayakumar, Linda J. Addonizio, Maryanne R. Kichuk-Chrisant, Mark E. Galantowicz, Jacqueline M. Lamour, Jan M. Quaegebeur, Daphne T. Hsu

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

The purpose of this study was to review the clinical course and outcome of cardiac transplantation after a failed Glenn or Fontan procedure. Late complications of the Glenn or Fontan procedure, including ventricular failure, cyanosis, protein-losing enteropathy, thromboembolism, and dysrhythmias often lead to significant morbidity and mortality. If other therapies are ineffective, cardiac transplantation is the only therapeutic recourse. Transplantation in this unique population presents significant challenges in the operative and perioperative periods. The anatomic diagnoses, previous operations, clinical status, and indications for transplantation were characterized in patients transplanted after a Glenn or Fontan procedure. Outcomes after transplantation, including postoperative complications and mortality, were reviewed. Comparisons were made between survivors and nonsurvivors. Primary orthotopic cardiac transplantation was performed in 35 patients (mean age 15.7 ± 8.5 years) with a mean follow-up of 54 ± 46 months. A total of 11 patients had undergone a Glenn shunt and 24 patients a Fontan procedure. Indications for transplantation were a combination of causes including ventricular dysfunction, failed Fontan physiology, and/or cyanosis. Ten patients died ≤2 months after transplantation; nine of the deaths occurred in the Fontan patients. Overall, one-year survival was 71.5%, and five-year survival was 67.5%. Survival was not significantly different between patients transplanted after a Glenn or Fontan procedure and patients transplanted for other etiologies. Cardiac transplantation can be performed successfully in patients with end-stage congenital heart disease after a Glenn or Fontan procedure, with outcomes similar to transplantation for end-stage heart failure secondary to other etiologies.

Original languageEnglish (US)
Pages (from-to)2065-2072
Number of pages8
JournalJournal of the American College of Cardiology
Volume44
Issue number10
DOIs
StatePublished - Nov 16 2004
Externally publishedYes

Fingerprint

Heart Transplantation
Fontan Procedure
Transplantation
Cyanosis
Survival
Protein-Losing Enteropathies
Ventricular Dysfunction
Perioperative Period
Mortality
Thromboembolism
Survivors
Heart Diseases
Heart Failure
Morbidity
Therapeutics

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Jayakumar, K. A., Addonizio, L. J., Kichuk-Chrisant, M. R., Galantowicz, M. E., Lamour, J. M., Quaegebeur, J. M., & Hsu, D. T. (2004). Cardiac transplantation after the Fontan or Glenn procedure. Journal of the American College of Cardiology, 44(10), 2065-2072. https://doi.org/10.1016/j.jacc.2004.08.031

Cardiac transplantation after the Fontan or Glenn procedure. / Jayakumar, K. Anitha; Addonizio, Linda J.; Kichuk-Chrisant, Maryanne R.; Galantowicz, Mark E.; Lamour, Jacqueline M.; Quaegebeur, Jan M.; Hsu, Daphne T.

In: Journal of the American College of Cardiology, Vol. 44, No. 10, 16.11.2004, p. 2065-2072.

Research output: Contribution to journalArticle

Jayakumar, KA, Addonizio, LJ, Kichuk-Chrisant, MR, Galantowicz, ME, Lamour, JM, Quaegebeur, JM & Hsu, DT 2004, 'Cardiac transplantation after the Fontan or Glenn procedure', Journal of the American College of Cardiology, vol. 44, no. 10, pp. 2065-2072. https://doi.org/10.1016/j.jacc.2004.08.031
Jayakumar KA, Addonizio LJ, Kichuk-Chrisant MR, Galantowicz ME, Lamour JM, Quaegebeur JM et al. Cardiac transplantation after the Fontan or Glenn procedure. Journal of the American College of Cardiology. 2004 Nov 16;44(10):2065-2072. https://doi.org/10.1016/j.jacc.2004.08.031
Jayakumar, K. Anitha ; Addonizio, Linda J. ; Kichuk-Chrisant, Maryanne R. ; Galantowicz, Mark E. ; Lamour, Jacqueline M. ; Quaegebeur, Jan M. ; Hsu, Daphne T. / Cardiac transplantation after the Fontan or Glenn procedure. In: Journal of the American College of Cardiology. 2004 ; Vol. 44, No. 10. pp. 2065-2072.
@article{cb34a483e1e248f3bed843120f2f0534,
title = "Cardiac transplantation after the Fontan or Glenn procedure",
abstract = "The purpose of this study was to review the clinical course and outcome of cardiac transplantation after a failed Glenn or Fontan procedure. Late complications of the Glenn or Fontan procedure, including ventricular failure, cyanosis, protein-losing enteropathy, thromboembolism, and dysrhythmias often lead to significant morbidity and mortality. If other therapies are ineffective, cardiac transplantation is the only therapeutic recourse. Transplantation in this unique population presents significant challenges in the operative and perioperative periods. The anatomic diagnoses, previous operations, clinical status, and indications for transplantation were characterized in patients transplanted after a Glenn or Fontan procedure. Outcomes after transplantation, including postoperative complications and mortality, were reviewed. Comparisons were made between survivors and nonsurvivors. Primary orthotopic cardiac transplantation was performed in 35 patients (mean age 15.7 ± 8.5 years) with a mean follow-up of 54 ± 46 months. A total of 11 patients had undergone a Glenn shunt and 24 patients a Fontan procedure. Indications for transplantation were a combination of causes including ventricular dysfunction, failed Fontan physiology, and/or cyanosis. Ten patients died ≤2 months after transplantation; nine of the deaths occurred in the Fontan patients. Overall, one-year survival was 71.5{\%}, and five-year survival was 67.5{\%}. Survival was not significantly different between patients transplanted after a Glenn or Fontan procedure and patients transplanted for other etiologies. Cardiac transplantation can be performed successfully in patients with end-stage congenital heart disease after a Glenn or Fontan procedure, with outcomes similar to transplantation for end-stage heart failure secondary to other etiologies.",
author = "Jayakumar, {K. Anitha} and Addonizio, {Linda J.} and Kichuk-Chrisant, {Maryanne R.} and Galantowicz, {Mark E.} and Lamour, {Jacqueline M.} and Quaegebeur, {Jan M.} and Hsu, {Daphne T.}",
year = "2004",
month = "11",
day = "16",
doi = "10.1016/j.jacc.2004.08.031",
language = "English (US)",
volume = "44",
pages = "2065--2072",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Cardiac transplantation after the Fontan or Glenn procedure

AU - Jayakumar, K. Anitha

AU - Addonizio, Linda J.

AU - Kichuk-Chrisant, Maryanne R.

AU - Galantowicz, Mark E.

AU - Lamour, Jacqueline M.

AU - Quaegebeur, Jan M.

AU - Hsu, Daphne T.

PY - 2004/11/16

Y1 - 2004/11/16

N2 - The purpose of this study was to review the clinical course and outcome of cardiac transplantation after a failed Glenn or Fontan procedure. Late complications of the Glenn or Fontan procedure, including ventricular failure, cyanosis, protein-losing enteropathy, thromboembolism, and dysrhythmias often lead to significant morbidity and mortality. If other therapies are ineffective, cardiac transplantation is the only therapeutic recourse. Transplantation in this unique population presents significant challenges in the operative and perioperative periods. The anatomic diagnoses, previous operations, clinical status, and indications for transplantation were characterized in patients transplanted after a Glenn or Fontan procedure. Outcomes after transplantation, including postoperative complications and mortality, were reviewed. Comparisons were made between survivors and nonsurvivors. Primary orthotopic cardiac transplantation was performed in 35 patients (mean age 15.7 ± 8.5 years) with a mean follow-up of 54 ± 46 months. A total of 11 patients had undergone a Glenn shunt and 24 patients a Fontan procedure. Indications for transplantation were a combination of causes including ventricular dysfunction, failed Fontan physiology, and/or cyanosis. Ten patients died ≤2 months after transplantation; nine of the deaths occurred in the Fontan patients. Overall, one-year survival was 71.5%, and five-year survival was 67.5%. Survival was not significantly different between patients transplanted after a Glenn or Fontan procedure and patients transplanted for other etiologies. Cardiac transplantation can be performed successfully in patients with end-stage congenital heart disease after a Glenn or Fontan procedure, with outcomes similar to transplantation for end-stage heart failure secondary to other etiologies.

AB - The purpose of this study was to review the clinical course and outcome of cardiac transplantation after a failed Glenn or Fontan procedure. Late complications of the Glenn or Fontan procedure, including ventricular failure, cyanosis, protein-losing enteropathy, thromboembolism, and dysrhythmias often lead to significant morbidity and mortality. If other therapies are ineffective, cardiac transplantation is the only therapeutic recourse. Transplantation in this unique population presents significant challenges in the operative and perioperative periods. The anatomic diagnoses, previous operations, clinical status, and indications for transplantation were characterized in patients transplanted after a Glenn or Fontan procedure. Outcomes after transplantation, including postoperative complications and mortality, were reviewed. Comparisons were made between survivors and nonsurvivors. Primary orthotopic cardiac transplantation was performed in 35 patients (mean age 15.7 ± 8.5 years) with a mean follow-up of 54 ± 46 months. A total of 11 patients had undergone a Glenn shunt and 24 patients a Fontan procedure. Indications for transplantation were a combination of causes including ventricular dysfunction, failed Fontan physiology, and/or cyanosis. Ten patients died ≤2 months after transplantation; nine of the deaths occurred in the Fontan patients. Overall, one-year survival was 71.5%, and five-year survival was 67.5%. Survival was not significantly different between patients transplanted after a Glenn or Fontan procedure and patients transplanted for other etiologies. Cardiac transplantation can be performed successfully in patients with end-stage congenital heart disease after a Glenn or Fontan procedure, with outcomes similar to transplantation for end-stage heart failure secondary to other etiologies.

UR - http://www.scopus.com/inward/record.url?scp=8144230398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8144230398&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2004.08.031

DO - 10.1016/j.jacc.2004.08.031

M3 - Article

C2 - 15542293

AN - SCOPUS:8144230398

VL - 44

SP - 2065

EP - 2072

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10

ER -